Families desperate to try and save their loved ones who are dying from COVID-19 have begun suing local hospitals that refuse to administer Ivermectin, a controversial drug not approved by the U.S. Food and Drug Administration (FDA) to treat COVID-19.
A judge ordered Rochester General Hospital on Friday to give a COVID-19 patient the experimental treatment as a last-ditch effort to save his life. It comes after the man’s daughter filed a lawsuit against the hospital to use the drug in an attempt to save her father.
Jeremy L. Carter, 75, was fully vaccinated when he tested positive for COVID-19 on Aug. 28. Less than a week later, he was admitted to Rochester General Hospital where doctors started COVID-19 treatment which included Remdesivir and Dexamethasone.
Unfortunately, the treatments did not work and his health continued to deteriorate.
On Sept. 20, after exhausting all COVID-19 treatments, Carter was transferred to ICU and placed on a ventilator. Carter’s daughter, Jill Alvarado started researching other alternative treatments. She found the drug Ivermectin, which is typically used to treat certain infections caused by parasitic worms, head lice, and skin conditions.
Alvarado spoke with Carter’s Primary Care provider who wrote him a prescription for Ivermectin but the hospital refused to administer it. Ivermectin has not been approved by the FDA to treat or prevent COVID-19 in humans or animals, however it has been given to some COVID-19 patients.
Recently, Ivermectin was prescribed to an 80-year-old woman in Buffalo who was in a similar situation. Within 48 hours after the first dose, she was transferred out of ICU and taken off a ventilator.
“Every case I have is a person in a hospital dying… what is the harm if a hospital is done with its protocol?” questioned Ralph Lorigo, the Western New York Attorney behind dozens of lawsuits that have been filed against health systems across the country over the last few months.
Carter’s suit is the third that Lorigo has filed against Rochester Regional Health to get them to administer Ivermectin.
“Each of those times we were successful and those people went home. In this situation we sued, we got a court order and the hospital refused to administer the Ivermectin,” Lorigo told News10NBC.
Rochester Regional Health filed an appeal on Saturday, a hearing was scheduled for Monday morning but Jeremy Carter died on Sunday.
Rochester Regional Health denied News10NBC’s requests for an interview/comment on these lawsuits.
Dr. Thomas Russo is the Chief of the Division of Infectious Diseases at the Jacobs School of Medicine at the University at Buffalo.
“Some studies have been done and to date, none of those studies have shown that Ivermectin benefits patients with COVID,” he told News10NBC, “there are still some ongoing studies but at this time we do not recommend it to use, it’s not recommended by the FDA, it’s not recommended by the infectious disease side of America.”
According to the FDA, clinical trials assessing Ivermectin tablets for the prevention or treatment of COVID-19 in people are ongoing.
STUDY: Aspirin Use Significantly Raises Risk of Heart Failure
Aspirin increases the risk of heart failure by over 25%
Aspirin is one of the most common pain relievers in the world, but a new study finds it may be contributing to heart failure. Researchers with the European Society of Cardiology find taking aspirin raises the risk of heart failure among people with at least one pre-existing health risk. These include smoking, being obese, having high blood pressure, high cholesterol, diabetes, or cardiovascular disease.
Aspirin has a complicated medical history. While some studies find regularly taking aspirin can help protect against illnesses like COVID-19 and cancer, others show it actually does more harm than good.
“This is the first study to report that among individuals with a least one risk factor for heart failure, those taking aspirin were more likely to subsequently develop the condition than those not using the medication,” says study author Dr. Blerim Mujaj of the University of Freiburg in a media release. “While the findings require confirmation, they do indicate that the potential link between aspirin and heart failure needs to be clarified.”
Older adults at high risk from aspirin use
In a study of nearly 31,000 people at risk of developing heart failure, the team found that aspirin users saw their chances of a heart failure diagnosis go up by 26 percent. Researchers defined “at risk” as anyone with a pre-existing health condition.
All of the participants were over the age of 40 and free of heart failure at the start of the experiment. The team recorded each person’s use of aspirin, separating them into two groups — users and non-users. Researchers followed up with the participants (who had an average age of 67) over a five-year period and after a person’s first fatal or non-fatal heart failure incident requiring hospitalization.
After accounting for influential factors like gender, weight, age, alcohol use, the use of medications, and various measures of health, the team concluded that aspirin independently contributes to increasing heart failure risk by more than a quarter among people with pre-existing health issues. Overall, 7,698 participants were taking aspirin and 1,330 developed heart failure over the next 5.3 years.
Even healthy people face dangers
To confirm their results, study authors compared the readings among aspirin users and non-users. They also examined the 74 percent of the study group that was free of cardiovascular disease (22,690 people) and found that using aspirin increased their risk of heart failure by 27 percent as well.
“This was the first large study to investigate the relationship between aspirin use and incident heart failure in individuals with and without heart disease and at least one risk factor. Aspirin is commonly used – in our study one in four participants were taking the medication. In this population, aspirin use was associated with incident heart failure, independent of other risk factors,” Dr. Mujaj concludes.
“Large multinational randomized trials in adults at risk for heart failure are needed to verify these results. Until then, our observations suggest that aspirin should be prescribed with caution in those with heart failure or with risk factors for the condition.”
The findings appear in the journal ESC Heart Failure.
Ivermectin Ends Covid in Japan
Ivermectin was allowed as a treatment in Japan on August 13, 2021 when Dr. Hauro Ozaki, Chairman of the Tokyo Medical Association, spoke on national TV about Ivermectin use in Africa and saying citizens should make their own decision to try it or not.
12 days later on August 25 the spike up in Covid cases reversed and plummeted to almost zero where it has remained.
Ivermectin was never “officially approved” as a Covid treatment.
In Japan, several websites are selling boxes of 50 12mg pills for ~6500 yen. Some of them went out of stock and restricted buying several boxes at a time. You get your Ivermectin in ~10 days.
Ireland bill proposes Government detain people suspected of having Covid, designate locations as “areas of infection”
Not even a confirmed infection, just suspicion.
Health1 day ago
108 FIFA players & coaches have died in the last 6 months alone
Politics4 weeks ago
Watch Patriot Purge, Tucker Carlson Documentary
Entertainment3 weeks ago
Something Extremely Dark Happened at Travis Scott’s Deadly “Astroworld” Festival
Local News4 weeks ago
11/3: AZ Gubernatorial Candidate Kari Lake Leads AZ Election Integrity Rally
Politics4 weeks ago
Pathetic Stunt: Dems Pose As White Nationalists ‘Supporting’ Glenn Youngkin
Health1 day ago
Wikipedia Stops Listing Athletes who Died While Playing Soccer as the Number Explodes
Politics3 weeks ago
FBI Spy Video Shows Kyle Rittenhouse Being Chased Down at Kenosha Riot…Which Explains Why You’ve Never Seen It
Health1 day ago
Ivermectin Ends Covid in Japan